Mankind Pharma Share Price in 2023: Chart, Monthly Trends, & Analysis
Advertisement
How did Mankind Pharma shares perform in 2023?
Let's find out!
Mankind Pharma share price in 2023 was ₹1,982.5 Its price on 1st January 2023 was ₹1,300, and by 31st December 2023 it moved to ₹1,982.5, giving a positive return of 52.5% for the year.
Mankind Pharma Share Open, High, Low, and Close prices for the Year 2023 are as follows:
| Open | High | Low | Close |
|---|---|---|---|
| ₹1,300 | ₹2,041.15 | ₹1,242 | ₹1,982.5 |
| 1st Jan 2023 | Occured in Nov 2023 | Occured in May 2023 | 31st Dec 2023 |
This page will help you understand how Mankind Pharma performed in 2023. Let's get started.
For complete insights into Mankind Pharma’s incredible stock price performance and growth, see: Mankind Pharma Historical Share Price Data from its IPO to 2024
Table: Mankind Pharma Share Monthly Close, Low, High Prices for 2023
Advertisement
| Month | Mankind Pharma | Change% | ↑High - ↓Low |
|---|---|---|---|
| May | ₹1,355.95 | - | ↑ ₹1,438.8 ↓ ₹1,242 |
| Jun | ₹1,699.75 | 25.3% | ↑ ₹1,768 ↓ ₹1,365.3 |
| Jul | ₹1,742.75 | 2.5% | ↑ ₹1,949 ↓ ₹1,661.05 |
| Aug | ₹1,802.9 | 3.4% | ↑ ₹1,945 ↓ ₹1,726.05 |
| Sep | ₹1,795.3 | -0.5% | ↑ ₹1,845 ↓ ₹1,693.6 |
| Oct | ₹1,741.55 | -3% | ↑ ₹1,848 ↓ ₹1,690 |
| Nov | ₹1,898.6 | 9% | ↑ ₹2,041.15 ↓ ₹1,683.05 |
| Dec | ₹1,982.5 | 4.4% | ↑ ₹2,030.95 ↓ ₹1,821 |
Chart: CandleStick and Line Chart Showing Monthly Prices
[Click on line name to show/hide a line]
What if You invested ₹10,000 in Mankind Pharma in 2023?
In 2023, the opening price of Mankind Pharma share was ₹1300.00. Today, the price stands at ₹2,423.35, reflecting a growth of 86.41%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2023 would have become ₹18,641.15 by 2024. This represents a CAGR of 86.41%.
You might also like to check: Mankind Pharma Stock Price in 2024
References:
Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.
Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.
